Here are three strategies that the federal government should consider to ensure that naloxone is truly accessible.
Communication is a Key Element of an Effective Community Response to Opioid Addiction
Open conversation about addiction is important, but it can perpetuate myths, discouragement, and stigma.
Acquainting Criminal Justice Professionals With Addiction Treatment Fundamentals
IRETA works with courts to ensure that individuals on community supervision are receiving appropriate, high-quality care.
Older Adults Deserve Healthcare That Considers Substance Use
Addiction is a growing issue for folks over 65, and prescription medicines pose additional risks.
Updates on a Prescription Drug Monitoring Program in Pennsylvania
Tracking progress on our home state’s efforts to modernize our PDMP and improve the quality of care that all patients receive.
Safe Injection Spaces Save Lives and Money, But Will They Make It in America?
Ten countries have authorized Supervised Injection Facilities in about 66 cities around the world.
3 Barriers to Medication-Assisted Treatment for Drug Court Participants and How They Can Be Overcome
Drug courts place eligible defendants in a treatment program, monitor their progress, and decide whether they have recovered sufficiently to have their cases dismissed. MAT has permeated only half of the drug courts in the country.
Surgeon General Murthy Said We Need To Reduce the Separation Between Addiction Treatment and Healthcare
People are dying, healthcare costs are rising, the stigma persists, and care is hard to access. Fortunately, no matter where Surgeon General Vivek Murthy, MD, MBA goes to work in the morning, he’s left us with a significant document to learn from and bring to life, the 2016 Surgeon General’s Report on Alcohol, Drugs, and Health.
The ‘Treat v. Punish’ Debate is Nothing New. But What is Good Treatment?
We know that treatment is more cost-effective (and compassionate) than punishment. But what we should really be talking about is good treatments.
Time for Drug Courts To Equip Participants with Naloxone
Individuals who use opioids after a period of abstinence are at a higher risk for overdose due to a lowered tolerance, a circumstance in which drug court participants with a history of opioid use may find themselves.
